Correction to: The Pharmacogenomics Journal (2012) 12, 205–213; doi:10.1038/tpj.2011.15
The above article was published with incomplete affiliations. The authors apologize for this error. The authors, with the correct affiliations, are listed below.
F Dionne1, C Mitton1,2, R Rassekh3, B Brooks4,5, C Ross6,7, M Hayden6,7 and B Carleton6,8,9
1Centre for Clinical Epidemiology and Evaluation, VCHRI, Vancouver, Canada; 2School of Population and Public Health, University of British Columbia, Vancouver, Canada; 3Department of Pediatrics, Division of Pediatric Hematology/Oncology/BMT, British Columbia Children's Hospital, Vancouver, Canada; 4Audiology and Speech Pathology Department, British Columbia's Children's Hospital, Vancouver, Canada; 5School of Audiology and Speech Sciences, University of British Columbia, Vancouver, Canada; 6Child and Family Research Institute, Children's and Women's Health Research Centre of B.C., Vancouver, Canada; 7Department of Medical Genetics, University of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, Canada; 8Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada and 9Department of Paediatrics, Pharmaceutical Outcomes Programme, University of British Columbia, Vancouver, Canada
Additional information
The online version of the original article can be found at 10.1038/tpj.2011.15
Rights and permissions
About this article
Cite this article
Dionne, F., Mitton, C., Rassekh, R. et al. Erratum: Economic impact of a genetic test for cisplatin-induced ototoxicity. Pharmacogenomics J 12, 359 (2012). https://doi.org/10.1038/tpj.2011.21
Published:
Issue Date:
DOI: https://doi.org/10.1038/tpj.2011.21
